Results 41 to 50 of about 269,068 (254)

A case of platelet transfusion refractoriness occurring after platelet transfusion for tooth extraction

open access: yesNihon Koku Geka Gakkai Zasshi, 2015
Hirokazu TANAKA   +5 more
exaly   +3 more sources

Efficacy of apheresis platelet transfusion in 310 patients with haematological diseases

open access: yesZhongguo shuxue zazhi, 2023
Objective To observe the effect of platelet transfusion in inpatients with haematological diseases, analyze the possible causes of platelet transfusion refractoriness (PTR), in order to further improve the efficacy of platelet transfusion.
Shisong YOU   +5 more
doaj   +1 more source

Platelet function analysed by ROTEM platelet in cardiac surgery after cardiopulmonary bypass and platelet transfusion

open access: yes, 2020
Objectives The aim of this study was to investigate whether ROTEM platelet can provide additional information to the traditional ROTEM analysis to guide treatment with platelet transfusions in cardiac surgery and to identify factors triggering platelet ...
Agneta Wikman   +11 more
core   +1 more source

Preoperative FIB‐4 Index as a Potential Factor Associated With Severe Postoperative Complications and Endogenous Organ Failure After Hepatectomy for Hepatocellular Carcinoma

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This study demonstrates that a preoperative FIB‐4 index ≥ 5.0 independently predicts severe complications and endogenous organ failure (EOF) following hepatectomy for hepatocellular carcinoma. By capturing structural liver fragility and systemic vulnerability, the FIB‐4 index enhances surgical risk stratification beyond traditional functional markers ...
Masanori Nakamura   +9 more
wiley   +1 more source

Prevalence and Factors associated with Platelet Refractoriness among Tanzanian Patients – A Cross-Sectional Study from The National Reference Hospital

open access: yes, 2023
Background A response to platelet transfusion is assessed by post transfusion platelet increment and failure to reach a desired increment is termed platelet refractoriness, which is best measured by the corrected count increment (CCI) which takes into ...
Luhulla, Koga Malunguja   +4 more
core   +1 more source

Targeting B‐Cell‐Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Current treatments for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), rare autoimmune diseases in which autoreactive B cells play a major role, can lead to high response rates; however, for many patients these responses are not durable or maintained after treatment discontinuation.
Matthieu Mahévas   +4 more
wiley   +1 more source

The Use Of A Potential Novel Tool In Virtual Crossmatching For Platelet Transfusion In Platelet Refractoriness

open access: yes, 2016
Background and Objectives: Transfusion support for immune-mediated platelet refractoriness (PR) is clinically challenging, technically laborious and costly.
Sousa, L C D M   +5 more
core   +2 more sources

Evaluation of PEscore performance in predicting platelet transfusion efficacy in hematological patients

open access: yesZhongguo shuxue zazhi
[Objective] To evaluate the performance of platelet efficacy score (PEscore) in predicting platelet transfusion efficacy in hematological patients. [Methods] A total of 485 patients with hematological diseases, including 298 males (62.09±15.45 years) and
LI Jun   +4 more
doaj   +1 more source

Comparison of a therapeutic platelet transfusion strategy to a prophylactic platelet transfusion strategy in autologous stem cell transplant (ASCT), a single centre experience

open access: yes, 2021
In 2016, the British Journal of Haematology platelet transfusion guideline suggests not giving prophylactic platelet transfusions to well ASCT patients with no bleeding [1].
Hickey, B   +3 more
core   +1 more source

Severe ADEM‐Like Neuroinflammatory Disease and Cerebrovascular Fragility With Recurrent Pseudoaneurysms and Moyamoya in a Familial Germline CBL Mutation: Expanding the Clinical Phenotype

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Heterozygous germline variants in CBL disrupt its function as a negative regulator of the Ras/MAPK pathway, classically predisposing to Juvenile myelomonocytic leukemia (JMML) and moyamoya. We describe two affected siblings carrying a paternally inherited CBL variant (c.1210 T> C, p.
Michal Bar‐Hakim   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy